Startups
Esco Aster is a contract development and manufacturing organization (CDMO) founded and deeply rooted by scientists enabling fellow scientists to translate their bench work into life-saving diagnostics, medicines, therapies, cosmeceuticals, and cellular agriculture, at affordable prices for self-sufficiency of the country.
We make complex manufacturing simple via our proprietary best-in-class continuous manufacturing platforms providing a reliable and linearly scalable outcome with track record of being used in 7 commercial human and animal health vaccines.
We continuously invest in meeting unmet clinical needs by unlocking manufacturing bottlenecks for current and new platform modalities.
Esco Aster operates on dedicated sites based on our applications of our manufacturing platforms each site has dedicated scientists working on specific modalities. Esco Aster will continue to scale up with our collaborators and partners for future commercial expansion in Singapore or as Internal Tech Transfer to client choice of country.
Together, we are working on an interconnected one health approach to bring your next molecule into the clinic and life.
Join us for the world we are making redefining medicine for the current and future generations to come.
Esco Aster.
One World. One Health
We make complex manufacturing simple via our proprietary best-in-class continuous manufacturing platforms providing a reliable and linearly scalable outcome with track record of being used in 7 commercial human and animal health vaccines.
We continuously invest in meeting unmet clinical needs by unlocking manufacturing bottlenecks for current and new platform modalities.
Esco Aster operates on dedicated sites based on our applications of our manufacturing platforms each site has dedicated scientists working on specific modalities. Esco Aster will continue to scale up with our collaborators and partners for future commercial expansion in Singapore or as Internal Tech Transfer to client choice of country.
Together, we are working on an interconnected one health approach to bring your next molecule into the clinic and life.
Join us for the world we are making redefining medicine for the current and future generations to come.
Esco Aster.
One World. One Health
Overview
Location
Singapore
Employees
11-50
Founded date
2017
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 6, 2026 | Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform | SINGAPORE, Jan. 6, 2026 /PRNewswire/ -- Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program. Shine-On ... |
| Oct 3, 2025 | Singapore’s ImpacFat Launches Cultivated Fish Fat R&D Center in Tokyo | ImpacFat, a biotechnology company from Singapore, has announced its expansion into Japan with the opening of a new research and development hub in Tokyo. Backed by strategic investments from major Japanese firms, this reinforces the company... |
| Nov 13, 2024 | $229 Billion Cultured Meat Market Trends and Forecast Estimates, 2020-2023, 2024, 2035 and 2050 – ResearchAndMarkets.com | DUBLIN–(BUSINESS WIRE)–The “Cultured Meat Market: Industry Trends and Forecasted Estimates to 2050 – Distribution by Source of Meat, Type of Cultivation Technique, Form of Meat Produced, End Products Offered and Key Geographical Region” rep... |
| Mar 28, 2024 | Meatable CTO on the cultivated meat industry cycle: ‘Hype, stagnation, consolidation, redirection’ | Dutch startup Meatable has slashed production times for cultivated pork in recent months by dramatically speeding up the process by which its stem cells differentiate into fat and muscle, further improving its unit economics at a time when ... |
| Sep 27, 2023 | Dutch foodtech firm to debut cultivated pork in Singapore next year | Consumer TechNewsStartups Melissa Goh · 27 Sep 2023 · 2 min readDutch foodtech firm to debut cultivated pork in Singapore next year The Meatable sausage, developed with plant-based butcher Love Handle, that’s one-third cultivated meat and t... |
| Aug 7, 2023 | Dutch cultivated meat startup Meatable raises $35m Series B, gears up for market entry in 2024 | Dutch cultivated meat startup Meatable has raised $35 million in a series B round led by Agronomics, taking its total funding to $95 million as it gears up to launch pork sausages and dumplings in Singapore next year. The round includes $17... |
| May 8, 2023 | Mosa Meat opens new facility in Maastricht, sees ‘a clear path towards price parity’ for cultivated meat | A decade after cofounder Dr. Mark Post unveiled the world’s first beef burger made from animal cells grown outside of an animal, Dutch cultivated meat startup Mosa Meat has opened a 30,000sq ft ‘scale-up plant’ in Maastricht as it edges clo... |
| Feb 16, 2023 | The Week in AgriFoodTech: GrainChain raises $29m, Brigad bags $30m, AeroFarms & iFarm head to MENA | This week, US-based GrainChain announced a $29 million raise for its ag supply chain platform, and hospitality tech startup Brigad landed $30 million. More vertical farming startups are headed to the Middle East North Africa (MENA) region, ... |
| Nov 16, 2022 | ‘Hybrid meat’? Meatable wants to get lab-grown meat to market faster by combining with plant-based proteins | Alternative meat, seafood and dairy products are all the rage in startup land, with countless companies raising bucketloads of cash and showcasing their first products throughout 2022. There are two broad categories within the meat-substitu... |
Show more
Reviews 0
FAQ about ESCO ASTER PTE LTD
When was ESCO ASTER PTE LTD founded?
ESCO ASTER PTE LTD was founded in 2017.
What has the press written about ESCO ASTER PTE LTD?
Parsers VC has collected 12 articles mentioning ESCO ASTER PTE LTD, among them “Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform” (Jan 6, 2026) and “Singapore’s ImpacFat Launches Cultivated Fish Fat R&D Center in Tokyo” (Oct 3, 2025).
Is ESCO ASTER PTE LTD still active?
Yes, ESCO ASTER PTE LTD is active; its latest activity on Parsers VC dates from Jul 29, 2026.